OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

4-Aminoquinoline-Based Adamantanes as Potential Anticholinesterase Agents in Symptomatic Treatment of Alzheimer’s Disease
Katarina Komatović, Ana Matošević, Nataša Terzić, et al.
Pharmaceutics (2022) Vol. 14, Iss. 6, pp. 1305-1305
Open Access | Times Cited: 13

Showing 13 citing articles:

Exploring diverse frontiers: Advancements of bioactive 4-aminoquinoline-based molecular hybrids in targeted therapeutics and beyond
Lekkala Ravindar, Siti Aishah Hasbullah, K.P. Rakesh, et al.
European Journal of Medicinal Chemistry (2023) Vol. 264, pp. 116043-116043
Closed Access | Times Cited: 17

Evaluation of 4-aminoquinoline derivatives with an n-octylamino spacer as potential multi-targeting ligands for the treatment of Alzheimer's disease
Ana Matošević, Dejan Opsenica, Marta Spasić, et al.
Chemico-Biological Interactions (2023) Vol. 382, pp. 110620-110620
Closed Access | Times Cited: 11

Nascent pharmacological advancement in adamantane derivatives
Aman Ragshaniya, Vijay Kumar, Ram Kumar Tittal, et al.
Archiv der Pharmazie (2023) Vol. 357, Iss. 3
Closed Access | Times Cited: 10

Design, Synthesis and Biological Evaluation of Biscarbamates as Potential Selective Butyrylcholinesterase Inhibitors for the Treatment of Alzheimer’s Disease
Ana Matošević, Anamarija Knežević, Antonio Zandona, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 10, pp. 1220-1220
Open Access | Times Cited: 10

Synthesis and biological evaluation of novel aminoquinolines with an n-octyl linker: Impact of halogen substituents on C(7) or a terminal amino group on anticholinesterase and BACE1 activity
Ana Matošević, Marija Bartolić, Nikola Maraković, et al.
Bioorganic & Medicinal Chemistry Letters (2024) Vol. 112, pp. 129928-129928
Closed Access | Times Cited: 1

Metal-free [2 + 2] and [4 + 2] cycloadditions ofN-aryl-substituted ynamides to construct functionalized aminocyclobutenes and 4-aminoquinolines
Lixia Ding, Zhifei Zhu, Xin-yue Zhou, et al.
Organic Chemistry Frontiers (2023) Vol. 10, Iss. 16, pp. 4043-4054
Closed Access | Times Cited: 3

Derivatives of Amodiaquine as Potent Human Cholinesterases Inhibitors: Implication for Treatment of Alzheimer’s Disease
Ana Matošević, Dejan Opsenica, Marija Bartolić, et al.
Molecules (2024) Vol. 29, Iss. 22, pp. 5357-5357
Open Access

Evaluation of hydrazone and N -acylhydrazone derivatives of vitamin B6 and pyridine-4-carbaldehyde as potential drugs against Alzheimer’s disease
Marija Bartolić, Ana Matošević, Nikola Maraković, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2024) Vol. 39, Iss. 1
Open Access

Potential of Vitamin B6 Dioxime Analogues to Act as Cholinesterase Ligands
Dajana Gašo-Sokač, Antonio Zandona, Sunčica Roca, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13388-13388
Open Access | Times Cited: 3

Role of Target Fishing in Discovery of Novel Anti-Alzheimer’s Agents: In Silico Applications
Anjali Murmu, Balaji Wamanrao Matore, Purusottam Banjare, et al.
(2023), pp. 245-284
Closed Access | Times Cited: 1

Aerobic Dehydrogenative Aromatization in the Preparation of 4-Aminoquinoline Derivatives by Synergistic Pd/Cu Catalysis
Fei Chen, Huidan Geng, Chun Li, et al.
The Journal of Organic Chemistry (2023) Vol. 88, Iss. 22, pp. 15589-15596
Closed Access

Page 1

Scroll to top